CGEM
Cullinan Therapeutics, Inc. Common Stock
stockNASDAQ
Market OpenNov 10, 2026 1:34:55 PM EST
11.19USD-4.646%(-0.54)377,474
Pre-marketNov 10, 2026 9:25:30 AM EST
11.62USD-0.938%(-0.11)
Loading…
Loading…
721.07M
Healthcare
Biotechnology
HQ
Cambridge, MA, USA
Previous Close
$11.73
Beta
1.56
52-Week High
$23.19 2026-08-26
52-Week Low
$7.25 2025-11-11
SMA 50
$16.77
SMA 200
$15.85
Avg. Vol 10D
923,502
Avg. Vol 30D
891,986
Avg. Vol 90D
848,049
Relative Vol
0.42
64.35M
48.20M
74.90%
7,640,003
15.89%
8.21
63%/37%
68.08%
49.25%
0.4300%
1,200,000
18
1,171
2,260
-165.5M
Nov 10, 2026
Cullinan Therapeutics reports Q3 results · 
Seeking Alpha
Nov 9, 2026
Cullinan Therapeutics to Participate in Upcoming Investor Conferences · 
GlobeNewswire Inc.
CGEM Profile
cullinan oncology is focused on investing in and developing a highly diversified portfolio of oncology therapeutics with a unique, cost-efficient business model. sourced from the cullinan dry lab as well as external collaborators, cullinan's assets are managed by a single, highly experienced team of oncology professionals and drug developers across a lean, capital efficient operating model.
CGEM Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 15.75 | 2026-11-03 | -28.86% | 1.264 |
| 1M | 15.53 | 2026-10-09 | -27.85% | 1.730 |
| 3M | 18.28 | 2026-08-10 | -38.71% | 1.933 |
| 6M | 14.73 | 2026-05-11 | -23.93% | 1.601 |
| 1Y | 7.44 | 2025-11-10 | +50.60% | 1.560 |
| 2Y | 17.27 | 2024-11-11 | -35.12% | — |
| 5Y | 22.49 | 2021-11-10 | -50.18% | 1.242 |
CGEM Stock Summary
Cullinan Therapeutics, Inc. Common Stock (NASDAQ:CGEM) stock price today is $11.20, and today's volume is 374,039. CGEM is down 4.479% today. The 30 day average volume is 891,986. CGEM market cap is $721.07M with 64.35M shares outstanding.